Loading clinical trials...
Loading clinical trials...
Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor - Randomized Double Blind Placebo Controlled Trial
Conditions
Interventions
micronized progesterone 400 mg (Utrogestan)
Locations
3
Israel
Poriya Medical Center
Tiberias, North, Israel
Emek Medical center
Afula, Please Select, Israel
Assuta Ashdod medical center
Ashdod, Israel
Start Date
December 19, 2018
Primary Completion Date
February 27, 2023
Completion Date
February 27, 2023
Last Updated
February 28, 2023
NCT07015203
NCT01829204
NCT04821544
NCT06968364
NCT06794307
NCT05698966
Lead Sponsor
HaEmek Medical Center, Israel
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions